Acquisition of Atrin Pharmaceuticals (Details) - Atrin Pharmaceuticals, Inc $ in Millions	May 16, 2022 USD ($) shares
Acquisition of Atrin
Cost to acquire Atrin assets \| $	$ 76.2
Direct costs of acquisition of Atrin assets \| $	$ 3.5
Common Stock
Acquisition of Atrin
Issuance of stock upon acquisition of Atrin (in shares) \| shares	55,869
Series A Convertible Preferred Stock
Acquisition of Atrin
Issuance of stock upon acquisition of Atrin (in shares) \| shares	2,949,630
Preferred stock conversion ratio	10

Costs incurred to effect a assets acquisition which have been expensed during the period

No definition available.

Name:	apre_AssetAcquisitionRelatedCost
Namespace Prefix:	apre_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 30
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 55
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 30
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of common shares issuable upon conversion for each share of preferred stock to be converted.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

+ Details

Name:	us-gaap_PreferredStockConvertibleConversionRatio
Namespace Prefix:	us-gaap_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AssetAcquisitionAxis=apre_AtrinPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=apre_ConvertiblePreferredStockSeriesaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: